Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.53 |
| ▸ | MEN1 | O00255 | 6/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | GRM8 | O00222 | 1/20 | 0.53 |
| ▸ | GRM6 | O15303 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.49 |
| ▸ | HPGD | P15428 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | RECQL | P46063 | 3/20 | 0.49 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9853831 | 0.82 | HSD17B10 (0.58) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| SCHEMBL29364937 | 0.82 | ALDH1A1 (0.68) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| SCHEMBL231377 | 0.82 | ALDH1A1 (0.68) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| SCHEMBL28520448 | 0.80 | ALDH1A1 (0.65) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| SCHEMBL2809853 | 0.80 | ALDH1A1 (0.65) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| SCHEMBL2810654 | 0.80 | ALDH1A1 (0.65) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| Nitrogen SCHEMBL28683357 | 0.78 | ALDH1A1 (0.63) | TDP1MEN1KMT2AHSD17B10CYP2C9 | |
| SCHEMBL12122146 | 0.78 | NOS3 (0.50) | TDP1MEN1KMT2AHSD17B10ALDH1A1 | |
| SCHEMBL56667 | 0.78 | NOS3 (0.50) | TDP1MEN1KMT2AHSD17B10ALDH1A1 | |
| SCHEMBL28038600 | 0.78 | NOS3 (0.50) | TDP1MEN1KMT2AHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1799791-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-01-13 | — | — | EP | claimed |
| CN-101040028-B | Photocrosslinkable materials | ROLIC AG | 2012-03-28 | — | — | CN | claimed |
| US-7687118-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2010-03-30 | — | — | US | claimed |
| US-20080069968-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-03-20 | — | — | US | claimed |
| CN-101040028-A | Photocrosslinkable materials | ROLIC AG (CH) | 2007-09-19 | — | — | CN | claimed |
| EP-1799791-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2007-06-27 | — | — | EP | claimed |
| WO-2006039824-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2006-04-20 | — | — | WO | claimed |
| EP-2152660-A2 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | Rolic AG (CH) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008145225-A2 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2008-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080069968-A1 | Photocrosslinkable Materials | PARG, VSIR, IGLV6-57 | TDP1 2088/4885MEN1 3530/4885KMT2A 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.